Geode Capital Management, LLC Processa Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.18 - $0.84 $5,514 - $25,735	-30,637 Reduced 20.07%	122,033 $41,000
Q3 2023 Nov 13, 2023	BUY	$0.24 - $0.53 $20,122 - $44,436	83,843 Added 121.82%	152,670 $38,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $50.0 $4,317 - $196,250	3,925 Added 6.05%	68,827 $75,000
Q3 2021 Nov 12, 2021	BUY	$5.28 - $8.61 $145,210 - $236,792	27,502 Added 73.53%	64,902 $556,000
Q2 2021 Aug 13, 2021	BUY	$6.15 - $10.95 $58,886 - $104,846	9,575 Added 34.41%	37,400 $306,000
Q1 2021 May 12, 2021	BUY	$5.96 - $13.15 $165,837 - $365,898	27,825 New	27,825 $303,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $13.6M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.